Track the Evgen Pharma plc stock price and the full insider trade history of the company, a listed equity based in United Kingdom. Shares trade on the UK market, under the authority of RNS (LSE). The latest transaction was disclosed on 5 April 2024 (Purchase). Among the most active insiders: Dr Helen Kuhlman. Every trade is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€65,316
6 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
Buys €65,316n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,000,000 shares@ £0.01100.0% of flowLondon Stock Exchange, AIM MarketRNS:5132376-5
6 of 6 declarations
About Evgen Pharma plc
Evgen Pharma plc is a UK-based biopharmaceutical company focused on developing treatments for cancer and neurodegenerative diseases. The company specializes in using gene therapy technology to enhance patient outcomes.